Cart
sales@molnova.com
Glycoprotein 276-286
CAS No. 160543-97-5
Glycoprotein 276-286( —— )
Catalog No. M30339 CAS No. 160543-97-5
Known Db-restricted peptide of lymphocytic choriomeningitis virus (LCMV).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
Biological Information
-
Product NameGlycoprotein 276-286
-
NoteResearch use only, not for human use.
-
Brief DescriptionKnown Db-restricted peptide of lymphocytic choriomeningitis virus (LCMV).
-
DescriptionKnown Db-restricted peptide of lymphocytic choriomeningitis virus (LCMV).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMicrobiology/Virology
-
TargetArenavirus
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number160543-97-5
-
Formula Weight1095.18
-
Molecular FormulaC46H70N12O17S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical NameSequence:{Ser}{Gly}{Val}{Glu}{Asn}{Pro}{Gly}{Gly}{Tyr}{Cys}{Leu}
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
Oldstone MB, et al. Discriminated selection among viral peptides with the appropriate anchor residues: implications for the size of the cytotoxic T-lymphocyte repertoire and control of viral infection. J Virol. 1995 Dec;69(12):7423-9.
molnova catalog
related products
-
ST-193
ST-193 (ST193) is a potent, selective, broad-spectrum arenavirus entry inhibitor with IC50 of 1.6 nM against LASV pseudotypes, targets arenavirus envelope glycoprotein.
-
GP(33-41)
GP(33-41), a 9-aa-long peptide, is the optimal sequence of the GP1 epitope of lymphocytic choriomeningitis virus, and can upregulate H-2Db molecules at the RMA-S (Db Kb) cell surface with a SC50 of 344 nM. GP33-41 Epitopeis a strong agonist of CD8 T cells from P14 TCR-transgenic mice.
-
LASV inhibitor 3.3
LASV inhibitor 3.3 (LAMP1 inhibitor 3.3) is a specific inhibitor of Lassa fever virus (LASV, IC50=1.8 uM).
